Treating invasive fungal disease (IFD) for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) before confirmatory tests is more effective than waiting for a test to confirm breakthrough disease (Microorganisms 2024;12[1]:117).
For example, one study that was part of the literature review found that among 549 AML/MDS patients undergoing induction chemotherapy or allogeneic stem cell transplantation, those who were treated with fluconazole prophylaxis